ABOUT THE EVENT

The Biotech Innovation & Investment Summit 2026 will bring together leading biotech executives, investors, and pharma strategists to explore the future of biotech acquisitions and the innovation pipelines that will shape large pharma portfolios over the next five years. 

With the global pharmaceutical industry increasingly reliant on external innovation to fuel growth, understanding which therapeutic areas, platform technologies, and business models will attract major acquisition interest is critical for biotech leaders and investors alike. 

Hosted at BDO’s offices on Viaduktstrasse in Basel, this late afternoon / early evening event will combine a keynote presentation, moderated panel discussion, and interactive Q&A session, followed by a networking apéro. 

The programme will focus on emerging industry trends, investment signals from large pharma, and the strategic implications for biotech companies positioning themselves for growth and partnership. 

SPEAKERS

Take a look at our speakers scheduled for this event

Jonathan K.C. Knowles

Former Head of Group Research, the Roche Group, Former executive chairman of Immunocore Ltd.

David Wentholt

Partner
BDO

Alexandra Zemp

Senior Partner
McKinsey & Company

Juliana Reis

Global Executive Director, M&A
Novartis

Manu Chhokra

Director of Partnerships
The British-Swiss Chamber of Commerce

Joseph Hammel

Head of Office Basel, Head of Audit and Partner
BDO

 SPONSORS 

121217 - BDO logo

 DAYS TO GO 

See you in 17 hours 26 minutes
  • 0
    Days
  • 17
    Hours
  • 26
    Minutes
  • 32
    Seconds

WHEN

24 September 2026
17:00-20:30

WHERE

BDO

Viaduktstrasse 42
Basel, 4051

PLANNER

The British-Swiss Chamber of Commerce

info@bscc.co.uk